<DOC>
	<DOCNO>NCT02707978</DOCNO>
	<brief_summary>The purpose research study evaluate tau distribution brain subject : FTD cause different genetic mutation , mutation carrier ( without symptom ) , non-mutation carrier , sporadic FTD , normal control .</brief_summary>
	<brief_title>F 18 T807 Tau PET Imaging Frontotemporal Dementia ( FTD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<criteria>1 . Male female participant , least 18 year age . 2 . Clinically diagnosed frontotemporal dementia ( FTD ) , carrier mutation know cause FTD ( without symptom ) ; normal control . 3 . Participant able willing undergo testing ( MRI CT , PET , radioactive tracer injection , LP ; unable undergo MRI , CT use generate regionsofinterest ) . 4 . Premenopausal woman negative urine pregnancy test within 24 hour T807 drug administration . 1 . Has condition , Investigator 's opinion , could increase risk participant , limit participant 's ability tolerate experimental procedure , interfere collection/analysis data ( example , participant severe chronic back pain might able lie still scan procedure ) . 2 . Is deem likely unable perform imaging procedure reason . 3 . Has history Torsades de Pointes take medication know prolong QT interval . To determine exclude study base criterion , review participant 's medical history current medication time screen . Participants exclude study follow restrict medication take : Disopyramide Dofetilide Ibutilide Procainamide Quinidine Sotalol Bepridil 4 . Has hypersensitivity F 18 T807 excipients . 5 . Contraindications PET , PETCT MR ( e.g . electronic medical device , inability lie still long period ) make unsafe individual participate . 6 . Severe claustrophobia . 7 . Currently pregnant breastfeeding . 8 . For elect undergo optional lumbar puncture : anticoagulant form prior lumbar puncture .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dementia</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>tauopathies</keyword>
	<keyword>Neurodegenerative Disease</keyword>
</DOC>